Department of Pathophysiology, Faculty of Medicine, Jagiellonian University Medical College, Kraków, Poland.
Second Department of Cardiology, Institute of Cardiology, Faculty of Medicine, Jagiellonian University Medical College, Kraków, Poland.
Folia Med Cracov. 2021 Sep 29;61(3):95-114. doi: 10.24425/fmc.2021.138954.
Microvascular angina (MVA) is a condition characterized by the presence of angina-like chest pain, a positive response to exercise stress tests, and no significant stenosis of coronary arteries in coronary angiography, with absence of any other specific cardiac diseases. The etiology of this syndrome is still not known and it is probably multifactorial. Coronary microvascular dysfunction is proposed as the main pathophysiological mechanism in the development of MVA. Altered somatic and visceral pain perception and autonomic imbalance, in addition to myocardial ischemia, has been observed in subjects with MVA, involving dynamic variations in the vasomotor tone of coronary microcirculation with consequent transient ischemic episodes. Other theories suggest that MVA may be a result of a chronic inflammatory state in the body that can negatively influence the endothelium or a local imbalance of factors regulating its function. This article presents the latest information about the epidemiology, diagnostics, etiopathogenesis, prognosis, and treatment of patients with MVA.
微血管性心绞痛(MVA)是一种以心绞痛样胸痛为特征的疾病,运动负荷试验阳性,冠状动脉造影显示冠状动脉无明显狭窄,且无其他特定的心脏疾病。该综合征的病因尚不清楚,可能是多因素的。冠状动脉微血管功能障碍被认为是 MVA 发展的主要病理生理机制。在 MVA 患者中观察到躯体和内脏疼痛感知改变和自主神经失衡,以及心肌缺血,涉及冠状动脉微循环血管舒缩张力的动态变化,导致短暂性缺血发作。其他理论认为,MVA 可能是机体慢性炎症状态的结果,这种状态会对内皮细胞产生负面影响,或局部调节其功能的因子失衡。本文介绍了 MVA 患者的最新流行病学、诊断、病因发病机制、预后和治疗信息。